Daniel Geffken
Board Member
Windtree Therapeutics Inc /De/ (WINT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Geffken
Daniel Geffken is recorded as Board Member at Windtree Therapeutics Inc /De/ (WINT). Windtree Therapeutics Inc /De/ reported in an 8-K filed August 14, 2024 that Daniel Geffken resigned as Board of Directors, effective August 13, 2024. Windtree Therapeutics Inc /De/ reported in an 8-K filed August 16, 2023 that Daniel Geffken was appointed Director, effective August 15, 2023.
“On August 13, 2024, Daniel Geffken and Leslie J. Williams each notified Windtree Therapeutics, Inc. (the "Company") of his or her resignation from the Board of Directors of the Company (the "Board"), including all committees of the Board on which he or she serves, effective August 13, 2024.”
“Daniel Geffken 728,246 34,509 1,480,055”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-15–present
-
2023-08-15–2024-08-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Windtree Therapeutics Inc /De/
Other people whose current roles at this company are on record from its filings.
- Jed Latkin CEO, Board Member
- Craig E. Fraser Chairman, Board Member
- Former Senior VP CFO
- Jamie McAndrew CFO, Chief Accounting Officer
- John Tattory CFO
- Senior VP CFO
- Diane Carman General Counsel
- Andrew Kucharchuk Board Member
- Dr. Evan Loh Board Member
- Dr. Robert Scott Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.